How Medical Device Companies Should Work With Physician Creators

Giang Le: Here is a sentence that should not be controversial but somehow still is in most device companies: a surgeon talking to other surgeons is worth more than an ad talking at everybody. I have watched device companies spend enormous budgets trying to buy the credibility that one respected physician creator gives away for free, and then wonder why it did not work. It did not work because they treated her like a rep. Let's talk about why that keeps happening and what actually works instead.

Giang Le: I'm Giang, founder of Studio Germina. We represent physician and healthcare creators, and we have also built go to market for clinical technology, which means I have sat on both sides of this exact table. So when I say most device companies use the physician creator channel badly, I mean I have watched it happen from inside the room. Medical device marketing has always run on peer credibility. A device gets adopted when a respected clinician uses it, talks about it, teaches it to colleagues. That is not new. What is new is that physician creators, clinicians with real audiences of other clinicians, do that at scale. It is one of the most effective channels a device company can use right now. And most companies still treat the physician creator like an influencer, or a rep, or a key opinion liaison from a decade ago. She is none of those things, and treating her that way is exactly why the good ones say no.

Giang Le: Clinicians trust clinicians. When a surgeon shows how a device changes a procedure, to an audience of surgeons who follow her specifically for that, she reaches the buyer at the exact moment they are deciding. No ad does that. No conference booth does that. The content also sits in search and keeps working long after it is posted, it compounds instead of expiring. And here is the part device marketers underrate: her audience is self selected by specialty. That is targeting precision no media buy can match. A hundred thousand general followers are worth less than eight thousand practicing specialists who actually use the device category. Size is not the metric. Composition is the metric.

Giang Le: So if composition is the metric, what do you actually need to offer to get the strong creators instead of the weak ones? Six things, and none of them are optional. First, evidence. The clinical data, the labeling, the honest limitations. A physician who cannot defend the device to a colleague will not promote it, full stop. Second, creative control. Her words, within regulatory review. The company approves for accuracy and compliance, it does not write the script. Third, fair market value, documented, because these payments get publicly reported and every physician creator knows that. Fourth, clear rights. Organic use on her own channels is hers, company use gets licensed separately and specifically. Perpetual, worldwide rights grabs get declined, and honestly, they should. Fifth, full disclosure, FTC and honesty with her audience, which protects the company just as much as it protects her. And sixth, a real relationship. Access to the clinical and product team, not just marketing. Early information. A voice in how the content gets used. Offer those six things and you get the creators worth having. Send a brief and a rate instead, and you get the ones nobody else would work with.

Giang Le: Assuming you want to do this right, here is the actual shape of it. Choose creators on audience composition, not follower count, I already said that but it is worth repeating because it is the number one mistake. Start with education, disease state or procedural content with the device in context, before you ask for branded promotion. It clears regulatory review more easily, and it builds her audience so the branded work later actually lands somewhere. Define deliverables precisely, format, length, platform, how many, the schedule, and the review process for each one. Write the compliance process directly into the agreement, who reviews it, how long that takes, what triggers a revision, and what she can do if review changes the substance of what she said. Pay fair market value and document the reasoning, so when that payment shows up in the public database she has something to point to. License the specific rights you will actually use for the term you will use them, and pay for that separately from the base fee. And measure honestly, reach into the target specialty, engagement, inbound inquiries, rep conversations that reference the content, and where you can trace it, evaluations and adoption. Not impressions. Impressions are a vanity number dressed up as a KPI.

Giang Le: Now the part nobody wants to talk about but everybody has to. Every claim in paid content has to match the approved labeling and include fair balance. Off label discussion in company paid content is a regulatory problem for the company first, not the creator. Payments and transfers of value to physicians get reported publicly, and compensation has to be fair market value for real work, never tied to purchasing or recommending. Regulatory, legal, and medical review it before it goes live, and the agreement should state all of that plainly. That is the compliance layer, and it is not optional. Here is the mistake list, and I promise you have seen at least three of these happen. Choosing creators by follower count. Sending a script instead of a brief. Asking for content that does not look sponsored, which, no. Offering exposure instead of payment. Demanding perpetual rights. Letting review drag on for six weeks. Paying below fair market value and calling it an honorarium. Treating the creator as a rep. Running one campaign and then disappearing. Every single one of those either drives away the creators worth having, or produces content their own audience ignores. And their audience can tell. Clinicians are not a naive audience.

Giang Le: So what does a good program actually look like, in practice? A small number of physician creators, chosen for audience composition and credibility, engaged over a year rather than one campaign. Given evidence and access. Paid properly and on time. Reviewed efficiently instead of endlessly. And measured on the outcomes that actually matter to the sales team, not the outcomes that look good in a slide deck. Companies that run it this way find it outperforms most of what they spend on conferences and media buys, and the creators who work with them become genuine advocates because the relationship earned that, it was not bought. If you are on the physician side of this, the short version is: you are the medical expert, you get to stay the medical expert. Somebody else should be handling the deal terms, the rights, the pricing, and the follow up, so the time you already spend online answering questions and teaching does not just disappear for free.

Giang Le: That is the whole shape of it. Evidence, control, fair value, clear rights, full disclosure, and a relationship that lasts longer than one campaign. That is how the channel works when it works, and it is genuinely one of the best channels a device company has, when they stop treating physicians like placements. If you are a physician or healthcare creator who is tired of negotiating your own rate on a device partnership, or you keep getting exposure instead of payment, that is exactly the gap we sit in at Studio Germina. You do the clinical work, the teaching, the content people actually trust, we handle the positioning, the contracts, the pricing, and the reporting that proves it worked. If you are a physician or healthcare creator who would rather just create, book a consultation at studio germina dot com, and we will handle the business side with you. The links are below, I will put them in the show notes. Thanks for spending this time with me, I'm Giang, this has been Beyond the Screen, I will talk to you next time.